Levothyroxine supplementation does not improve heart transplantation from brain-dead donors
Nature Reviews Cardiology, Published online: 08 December 2023; doi:10.1038/s41569-023-00980-1The use of intravenous levothyroxine does not increase the likelihood of hearts being transplanted from haemodynamically unstable, brain-dead potential donors, suggesting that current practice recommendations should be revised.
Source: Nature Reviews Cardiology - Category: Cardiology Authors: Gregory B. Lim Source Type: research
More News: Brain | Cardiology | Heart | Heart Transplant | Levothyroxine | Neurology | Synthroid | Transplants